Abstract
Purpose
The relationship of CAN and BMD, fracture risk is still unclear in T2DM. The aim of the present study is to investigate the correlation between heart rate variability (HRV) and BMD in T2DM.
Methods
The study included 276 patients with T2DM aged ≥ 50 years, and Cardiovascular Autonomic Reflex Tests (CARTs) were applied to divide patients into two groups: CAN ( ±). 24 h Ambulatory ECG was assessed for HRV, BMD was measured by dual-energy X-ray bone densitometry, and FRAX scores were calculated for 10-year hip fracture risk (HF1) and major osteoporotic fracture risk (MOF). Adjusted regression analysis was performed to investigate influence factors for BMD and fracture risk. ROC curve was used to analyze the optimal cut-off point of LF/HF for screening osteoporosis.
Results
Baseline data showed significant differences in the duration of T2DM, insulin resistance index (HOMA-IR), 25-hydroxyvitamin D[25(OH)D], femoral neck BMD, hip BMD, lumbar BMD, HF1, and MOF between the CAN ( +) and CAN (−) groups. The proportion of patients with osteoporosis increased as the degree of CAN lesion increased. Correlation analysis showed that LF/HF was significantly correlated with BMD, especially with hip (r = − 0.534, p < 0.001). Regression analysis showed that LF/HF was a risk factor for reduced BMD and increased fracture risk. The optimal cut-point value for LF/HF to predict osteoporosis by ROC curve analysis was 3.17.
Conclusions
CAN is associated with reduced BMD and increased fracture risk in patients with T2DM, and LF/HF may have the potential to be a predictor of diabetic osteoporosis and have some clinical value in early diagnosis of diabetic osteoporosis and non-traumatic fractures in T2DM.
Similar content being viewed by others
Abbreviations
- BMD:
-
Bone mineral density
- HRV:
-
Heart rate variability
- HF1 :
-
Hip fracture risk
- MOF:
-
Major osteoporotic fracture risk
- HOMA-IR:
-
Insulin resistance index
- 25(OH)D:
-
25-Hydroxyvitamin D
- SBP:
-
Systolic blood pressure
- DBP:
-
Diastolic blood pressure
- FPG:
-
Fasting plasma glucose
- HbA1c:
-
Glycosylated hemoglobin
- TC:
-
Cholesterol
- TG:
-
Triglyceride
- LDL-C:
-
Low-density lipoprotein cholesterol
- HDL-C:
-
High-density lipoprotein cholesterol
- OC:
-
Osteocalcin
- PTH:
-
Parathyroid hormone
- BALP:
-
Bone alkaline phosphatase
- RANKL:
-
Receptor activator of nuclear factor-κB ligand
References
Freeman R (2014) Diabetic autonomic neuropathy. Handy Clin Neurol 126:63–79. https://doi.org/10.1016/b978-0-444-53480-4.00006-0
Chen HT, Lin HD, Won JG, Lee CH, Wu SC, Lin JD et al (2008) Cardiovascular autonomic neuropathy, autonomic symptoms and diabetic complications in 674 type 2 diabetes. Diabetes Res Clin Pract 82:282–290. https://doi.org/10.1016/j.diabres.2008.08.012
Agashe S, Petak S (2018) Cardiac autonomic neuropathy in diabetes mellitus. Methodist Debakey Cardiovasc J 14:251–256. https://doi.org/10.14797/mdcj-14-4-251
Sardu C, Massimo Massetti M, Rambaldi P, Gatta G, Cappabianca S, Sasso FC et al (2022) SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study. Metabolism. https://doi.org/10.1016/j.metabol.2022.155243
Paolisso P, Bergamaschi L, Rambaldi P, Gatta G, Foà A, Angeli F et al (2021) Impact of admission hyperglycemia on heart failure events and mortality in patients with Takotsubo syndrome at long-term follow-up: data from HIGH-GLUCOTAKO investigators. Diabetes Care 44(9):2158–2161. https://doi.org/10.2337/dc21-0433
Cygankiewicz I, Zareba W (2013) Heart rate variability. Handb Clin Neurol 117:379–393. https://doi.org/10.1016/b978-0-444-53491-0.00031-6
Coopmans C, Zhou TL, Henry RMA, Heijman J, Schaper NC, Koster A et al (2020) Both prediabetes and type 2 diabetes are associated with lower heart rate variability: the Maastricht study. Diabetes Care 43(5):1126–1133. https://doi.org/10.2337/dc19-2367
Sardu C, Paolisso P, Santamaria M, Sacra C, Pieretti G, Rizzo MR et al (2019) Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study. Diabetes Res Clin Pract 151:152–162. https://doi.org/10.1016/j.diabres.2019.04.015
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL et al (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305–317. https://doi.org/10.1016/s0092-8674(02)01049-8
Stein PK, Buzkova P, Fink HA, Robbins JA, Mukamal KJ, Cauley JA et al (2021) Cardiovascular autonomic nervous system function and hip fracture risk: the Cardiovascular Health Study. Arch Osteoporos 16(1):163. https://doi.org/10.1007/s11657-021-01028-y
Hansen CS, Theilade S, Lajer M, Hansen TW, Rossing P (2018) Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes. Diabet Med 35:1596–1604. https://doi.org/10.1111/dme.13777
Maser RE, Stabley JN, Lenhard MJ, Provost-Craig MA (2009) Autonomic nerve fiber function and bone mineral density in individuals with type 1 diabetes: a cross-sectional study. Diabetes Res Clin Pract 84:252–258. https://doi.org/10.1016/j.diabres.2009.02.012
Lin K, Wei L, Huang Z, Zeng Q (2017) Combination of Ewing test, heart rate variability, and heart rate turbulence analysis for early diagnosis of diabetic cardiac autonomic neuropathy. Medicine (Baltimore) 96:e8296. https://doi.org/10.1097/md.0000000000008296
Kara Z, Güneş M, Bolayırlı İM, Oşar Siva Z (2022) The effects of diabetic polyneuropathy and autonomic neuropathy on bone turnover. Metab Syndr Relat Disord 20:11–19. https://doi.org/10.1089/met.2021.0028
Motataianu A, Barcutean L, Bajko Z, Stoian A, Maier S, Voidazan S, Balasa R (2021) Autonomic and somatic nerve functions in type 2 diabetes mellitus patients: electrophysiological aspects. Diagnostics (Basel). https://doi.org/10.3390/diagnostics11112005
Goit RK, Khadka R, Sharma SK, Limbu N, Paudel BH (2012) Cardiovascular autonomic function and vibration perception threshold in type 2 diabetes mellitus. J Diabetes Complications 26:339–342. https://doi.org/10.1016/j.jdiacomp.2012.03.026
Takeuchi T, Tsuboi T, Arai M, Togari A (2001) Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 61(5):579–586. https://doi.org/10.1016/s0006-2952(00)00591-8
Togari A, Arai M (2008) Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J Pharmacol Sci 106:542–546. https://doi.org/10.1254/jphs.fm0070227
Spieker J, Frieß JL, Sperling L, Thangaraj J, Vogel-Höpker A, Layer PG (2020) Cholinergic control of bone development and beyond. Int Immunopharmacol 83:106405. https://doi.org/10.1016/j.intimp.2020.106405
Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397. https://doi.org/10.1161/circulationaha.106.634949
Cundy TF, Edmonds ME, Watkins PJ (1985) Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med 2:461–464. https://doi.org/10.1111/j.1464-5491.1985.tb00683.x
Benichou T, Pereira B, Mermillod M, Tauveron I, Pfabigan D, Maqdasy S et al (2018) Heart rate variability in type 2 diabetes mellitus: a systematic review and meta-analysis. PLoS ONE 13:e0195166. https://doi.org/10.1371/journal.pone.0195166
Risk M, Bril V, Broadbridge C, Cohen A (2001) Heart rate variability measurement in diabetic neuropathy: review of methods. Diabetes Technol Ther 3:63–76. https://doi.org/10.1089/152091501750220028
Kanis JA, Harvey NC, Johansson H, Odén A, Leslie WD, McCloskey EV (2017) FRAX Update J Clin Densitom 20:360–367. https://doi.org/10.1016/j.jocd.2017.06.022
Champakanath A, Keshawarz A, Pyle L, Snell-Bergeon JK, Shah VN (2021) Fracture risk assessment (FRAX) without BMD and risk of major osteoporotic fractures in adults with type 1 diabetes. Bone 143:115614. https://doi.org/10.1016/j.bone.2020.115614
Jung CH, Jung SH, Kim KJ, Kim BY, Kim CH, Kang SK et al (2015) The relationship between vitamin D status and cardiac autonomic neuropathy in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 12:342–351. https://doi.org/10.1177/1479164115588546
Silva LSD, de Queiroz NNM, de Melo FTC, Abrahão Neto JF, Janaú LC et al (2020) Improvement in cardiovascular autonomic neuropathy after high-dose vitamin D supplementation in patients with type 1 diabetes. Front Endocrinol (Lausanne) 11:605681. https://doi.org/10.3389/fendo.2020.605681
Katsanos S, Mavrogenis AF, Kafkas N, Sardu C, Kamperidis V, Katsanou P et al (2017) Cardiac Biomarkers predict 1-year mortality in elderly patients undergoing hip fracture surgery. Orthopedics 40(3):e417–e424. https://doi.org/10.3928/01477447-20170109-02
Laudisio A, Marzetti E, Antonica L, Cocchi A, Bernabei R, Zuccalà G (2008) Association of left ventricular function with bone mineral density in older women: a population-based study. Calcif Tissue Int 82(1):27–33. https://doi.org/10.1007/s00223-007-9094-1
Jackuliak P, Kužma M, Payer J (2019) Effect of antidiabetic treatment on bone. Physiol Res 68(Suppl 2):S107-s120. https://doi.org/10.33549/physiolres.934297
Funding
This study was supported by The Natural Science Foundation of Gansu Province in 2021(No. 21JR1RA080) and The First Hospital of Lanzhou University Foundation in 2019 (No. ldyyn2019-39).
Author information
Authors and Affiliations
Contributions
All authors participated in the conception and design of the study. Also, they participated in data collection, statistical analysis, and interpretation of data, drafted the submitted article, and accomplished the final approval of the version to be submitted.
Corresponding author
Ethics declarations
Conflict of interest
Yangyang Zhang, Jia Bai, Lingling Li, Hong Yang, Ying Yang, and Haihong Lv declare that they have no conflict of interest.
Research involving human participants and/or animals
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (the Ethics Committee of the First Hospital of Lanzhou University, China) and with the Helsinki Declaration of 1964 and later versions.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, Y., Bai, J., Li, L. et al. Research for correlation between heart rate variability parameters and bone mineral density in patients of type 2 diabetes mellitus. J Endocrinol Invest 46, 79–88 (2023). https://doi.org/10.1007/s40618-022-01886-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-022-01886-4